Treadwell Therapeutics is based in New York. It has raised $118M in total funding. Latest round: Series B. Backed by Sino Biopharmaceutical Limited, 3W Fund.
Treadwell Therapeutics is based in New York. Treadwell Therapeutics has raised $118M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in November 2021. The round record for Treadwell Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Sino Biopharmaceutical Limited, 3W Fund. 2 distinct backers are named across the disclosed rounds.
Every Treadwell Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in New York at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026